By Josh White
Date: Thursday 05 Jan 2023
(Sharecast News) - Liquid biopsy specialist Angle said in an update on Thursday that actions taken to control its cost base, and the closure of its Canadian operations, left it on track to deliver expected cost savings of £2.6m in 2023 and £4m per annum after that.
By Josh White
Date: Tuesday 19 Jul 2022
(Sharecast News) - Liquid biopsy specialist Angle had two entries on the list of director buys on Tuesday, after its chief executive and chief financial officers invested in shares.
By Iain Gilbert
Date: Wednesday 22 Jun 2022
(Sharecast News) - Liquid biopsy company Angle has secured an additional contract with its first large-scale pharmaceutical services customer.
Currency | UK Pounds |
Share Price | 20.69p |
Change Today | -0.81p |
% Change | -3.78 % |
52 Week High | 156.00 |
52 Week Low | 19.80 |
Volume | 1,991,519 |
Shares Issued | 260.58m |
Market Cap | £53.91m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
15:34 | 15,696 @ 20.20p |
15:14 | 30,000 @ 20.49p |
15:13 | 25,000 @ 20.15p |
15:13 | 5,000 @ 20.15p |
15:12 | 25,000 @ 20.13p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Garth Selvey |
You are here: research